1. 428 Interim analysis of Phase 2 results for cemiplimab in patients with metastatic basal cell carcinoma (mBCC) who progressed on or are intolerant to hedgehog inhibitors (HHIs). (10th December 2020) Authors: Lewis, Karl; Peris, Ketty; Sekulic, Aleksandar; Stratigos, Alexander; Dunn, Lara; Eroglu, Zeynep; Chang, Anne Lynn; Migden, Michael; Li, Siyu; Mohan, Kosalai; Coates, Ebony; Okoye, Emmanuel; Baurain, Jean-François; Bechter, Oliver; Hauschild, Axel; Butler, Marcus; Hernandez-Aya, Leonel; Licitra, ... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti‐Hu‐Associated Autoimmune Limbic Encephalitis in a Patient with PD‐1 Inhibitor‐Responsive Myxoid Chondrosarcoma. (20th November 2017) Authors: Papadopoulos, Kyriakos P.; Romero, Rebecca S.; Gonzalez, Gabriela; Dix, James E.; Lowy, Israel; Fury, Matthew Journal: Oncologist Issue: Volume 23:Number 1(2018) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer. Issue 3 (11th February 2019) Authors: Novoplansky, Ofra; Fury, Matthew; Prasad, Manu; Yegodayev, Ksenia; Zorea, Jonathan; Cohen, Limor; Pelossof, Raphael; Cohen, Liz; Katabi, Nora; Cecchi, Fabiola; Joshua, Ben‐Zion; Popovtzer, Aron; Baselga, Jose; Scaltriti, Maurizio; Elkabets, Moshe Journal: International journal of cancer Issue: Volume 145:Issue 3(2019) Page Start: 748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OncoTree: A Cancer Classification System for Precision Oncology. (2021) Authors: Kundra, Ritika; Zhang, Hongxin; Sheridan, Robert; Sirintrapun, Sahussapont Joseph; Wang, Avery; Ochoa, Angelica; Wilson, Manda; Gross, Benjamin; Sun, Yichao; Madupuri, Ramyasree; Satravada, Baby A.; Reales, Dalicia; Vakiani, Efsevia; Al-Ahmadie, Hikmat A.; Dogan, Ahmet; Arcila, Maria; Zehir, Ahme... Journal: JCO Clinical Cancer Informatics Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Paper 36: Change in Humeral Anchor Position Significantly Affects Isometry in UCL Repair: A 3-Dimensional Computer Modeling Study. Issue 7 (30th July 2022) Authors: Fury, Matthew; Liu, Tianyu; Oh, Luke; O'Donnell, Evan Journal: Orthopaedic journal of sports medicine Issue: Volume 10:Issue 7(2022)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Performance Analytics and Pitch Metrics as Predictors of Ulnar Collateral Ligament Injury in Major League Baseball Pitchers (128). Issue 10 (31st October 2021) Authors: Fury, Matthew; Scarborough, Donna; Oh, Luke; Wright-Chisem, Joshua; Fury, Jacob; Berkson, Eric Journal: Orthopaedic journal of sports medicine Issue: Volume 9:Issue 10(2021)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony-Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. (22nd May 2021) Authors: Babiker, Hani; Brana, Irene; Mahadevan, Daruka; Owonikoko, Taofeek; Calvo, Emiliano; Rischin, Danny; Moreno, Victor; Papadopoulos, Kyriakos P.; Crittenden, Marka; Formenti, Silvia; Giralt, Jordi; Garrido, Pilar; Soria, Ainara; Hervás-Morón, Asunción; Mohan, Kosalai Kal; Fury, Matthew; Lowy, Israe... Journal: Oncologist Issue: Volume 26:Number 9(2021) Page Start: e1508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony‐Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma. (22nd May 2021) Authors: Babiker, Hani; Brana, Irene; Mahadevan, Daruka; Owonikoko, Taofeek; Calvo, Emiliano; Rischin, Danny; Moreno, Victor; Papadopoulos, Kyriakos P.; Crittenden, Marka; Formenti, Silvia; Giralt, Jordi; Garrido, Pilar; Soria, Ainara; Hervás‐Morón, Asunción; Mohan, Kosalai Kal; Fury, Matthew; Lowy, Israe... Journal: Oncologist Issue: Volume 26:Number 9(2021) Page Start: e1508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Poster 202: Patellar Stabilization Procedures Not Performed to Address Alta Decrease Patellar Height. Issue 7 (30th July 2022) Authors: Anderson, Gregory; Hart, Joseph; Shank, Kaitlyn; Yalçin, Sercan; Fury, Matthew; Elias, John; Tanaka, Miho; Farrow, Lutul; Diduch, David; Cosgarea, Andrew; Kreulen, Timothy Journal: Orthopaedic journal of sports medicine Issue: Volume 10:Issue 7(2022)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810. Issue 1 (December 2016) Authors: Falchook, Gerald; Leidner, Rom; Stankevich, Elizabeth; Piening, Brian; Bifulco, Carlo; Lowy, Israel; Fury, Matthew Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗